- FDA reiterates warning of muscle injury risk when heart drugs combined
- In Brief: PreMD Inc.
- FDA places partial clinical hold on Celgene, MethylGene's cancer drug trials
- FDA reports new cases of pancreatitis seen with Byetta
- Santhera Pharmaceuticals' investigational congenital muscular dystrophy drug receives orphan drug designation
- Eight-week nicotine replacement therapy program improves quit rates compared with a two-week program, study shows
- Certain Medicare beneficiary subgroups failed to fill prescriptions before Part D implementation, new data show
- In Brief: California
- Concomitant asthma, COPD versus either disease alone linked with higher burden, data reveal
- In Brief: Illinois Gov. Rod Blagojevich
Home :: Pediatrics :: Pediatrics Conferences
APA 2007 Annual Meeting - ADHD track
May 19-24, 2007 San Diego, CA- Extended-release dexmethylphenidate effective in controlling ADHD in children with combined subtype
- Long-term treatment with lisdexamfetamine safe, effective in children with ADHD
- Experts highlight cognitive symptoms of ADHD, efficacy of available treatments
- Atomoxetine reduces ADHD symptoms, heavy drinking events in adults with ADHD, alcoholism, findings suggest
- Transdermal methylphenidate effectively treats ADHD, improves quality of life in children who switch from ER methylphenidate, research reveals
U.S. Psychiatric & Mental Health Congress 2007
October 11-14, 2007 Orlando, FL- Improving outcomes in adolescents, adults with ADHD
- Once identified, adult ADHD may be managed effectively with drugs, psychosocial therapy, experts suggest
- Lisdexamfetamine improves parent-rated measures of ADHD
- Guanfacine XR effective, safe in long-term treatment of ADHD
- OROS methylphenidate safe, effective in adults with ADHD, trial data show
AACAP 54th Annual Meeting
October 23-28, 2007 Boston, MA- Triple-bead MAS improves ADHD symptoms in adults, data indicate
- Guanfacine XR does not affect daytime sleepiness, increases evening sleepiness in children, adolescents with ADHD, safety analysis shows
- Dexmethylphenidate extended release at daily doses as high as 30 mg yields improvements in teacher-rated reports of children with ADHD
- Lisdexamfetamine beneficial for adults with ADHD, new data indicate
- Choosing best therapy for ADHD difficult, requires consideration of several factors
- AISRS useful in measuring methylphenidate therapy for adults with ADHD
- Transdermal methylphenidate effectively treats ADHD, improves quality of life in children who switch from ER methylphenidate, research reveals
- Methylphenidate transdermal system shows similar efficacy in male, female children with ADHD, although males may face greater risk of adverse events
- Abuse potential with OROS methylphenidate lower than with other methylphenidate formulations
- Guanfacine XR effective, safe in treating ADHD in children, adolescents, researchers report
- Substantial proportion of food-related anaphylactic reactions among children require multiple doses of epinephrine, study concludes
- Cranial radiotherapy tied to elevated adiposity, metabolic risk in ALL survivors
- Gut-directed hypnotherapy effective for persistent IBS in children
- Rapid response team reduces mortality in children's hospital
- Most cases of T-cell precursor ALL appear to develop after birth
All material on this Web site is protected by copyright. Copyright © 1994-2008 by VerusMed, a ConnectivHealth company. This Web site may also contain material copyrighted by third parties.